Pharmacy benefit management firm MC-Rx places the wearable device as a preferred treatment on its formulary
It’s called the strongest headache that affects people and it has clear, defining characteristics. But why does it appear in the fall? Who suffers from it? Which treatments are available?
At two hours post-treatment, pain freedom was achieved by 37% of participants with REN compared to 9% of the participants who took oral triptans and over the counter analgesic medications.
The device will be used to soothe episodic and chronic migraines among adolescents who are 12 years and older.
It is the first device of its kind considered safe for outpatient use.
JPOST Digital Library
